ARCHIVES

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

This article is from The Cancer Letter archive.

Vol. 08 No. 13 | March 26, 1982

Download PDF Visit The Full Archive

Related Articles

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

DeVita Swearing In Schedule Aug. 8

August 1, 1980

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

House Members Urge FDA to Review Fast Track Policies

July 5, 2002